PharmiWeb.com - Global Pharma News & Resources
07-Jun-2022

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.

A senior HR professional with decades of experience with global corporates, Mans joins coming from Royal Reesink (the Netherlands), a global distributor and services provider employing over 3,000 people worldwide, where she worked as Group HR Director.

Speaking on her new role, Mans explains: “DFE Pharma is recognized for having some of the best people in the industry working across its portfolio and I’m really looking forward to building on this reputation and continuing to do the best for our employees. As a rapidly growing global excipient business, expanding across many new and exciting areas in the pharma and biopharma sectors, we have many reasons why people would like to be a part of our journey. A big part of our continuing success will be how we develop and support our teams, be that leaders, researchers or business management staff,” says Mans.

Announcing the senior appointment, DFE Pharma CEO Martti Hedman said, "We are delighted to welcome Marie-Louise Mans to the Leadership Team. Her wealth of experience in leadership development, organizational planning, and HR strategy, in general, is critical to us in the current competitive recruitment climate. Marie-Louise has overseen the HR function of multiple global companies and we are excited to have someone of her caliber to lead this area.”

 

For more information on DFE Pharma, visit: www.dfepharma.com

-END-

About DFE Pharma

DFE Pharma is a global leader in pharma- and nutraceutical excipient solutions. We strive to develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical, and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients are used in numerous medicinal and nutraceutical products, including COVID-19 vaccines and - treatments.

Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With more than a century of experience and around 450 people worldwide, we are serving over 5,000 customers in 100+ countries worldwide. Headquartered in Goch, Germany, DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives, driven by our purpose your medicines, our solutions. Moving to a healthier world.

Learn more at www.dfepharma.com or follow us on social media.

--------------------------

Media Contact:
Amanda Leweson - Discovery PR, on behalf of DFE Pharma
Email: amanda@discovery-pr.com   
Mobile: + 44 (0) 7852 153 791     Office:   +44 (0) 1606 889 194   

Editor Details

Related Links

Last Updated: 07-Jun-2022